Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care
- PMID: 30896771
- PMCID: PMC6567824
- DOI: 10.1001/jamaoncol.2019.0062
Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care
Abstract
Importance: The recent parenteral opioid shortage (POS) has potential implications for cancer-related pain management in hospitalized patients.
Objective: This study compared changes in opioid prescriptions and clinically improved pain (CIP) among patients treated by an inpatient palliative care (PC) team before and after our institution first reported the POS.
Design, setting, and participants: A cohort study of 386 eligible patients with cancer treated at a comprehensive cancer center 1 month before and after the announcement of the POS. We reviewed data from electronic health records, including patient demographics, opioid type, route of administration, and dose. Board-certified palliative care specialists assessed CIP at follow-up day 1.
Exposures: The announcement of the POS by the institution's pharmacy and therapeutics committee on February 8, 2018.
Main outcomes and measures: The primary outcome was to measure the change in opioid prescription patterns of physicians, and the secondary outcome was to measure the proportion of patients who achieved CIP before and after announcement of the POS.
Results: Of 386 eligible patients, 196 were men (51%), 270 were white (70%), and the median age was 58 years (interquartile range, 46-67 years). Parenteral opioids were prescribed less frequently by the referring oncology teams after the POS (56 of 314 [18%]) vs before the POS (109 of 311 [35%]) (P < .001). The PC team also prescribed fewer parenteral opioids after the POS (96 of 336 [29%]) vs before the POS (159 of 338 [47%]) (P < .001). After the POS (vs before the POS), significantly fewer patients achieved CIP on follow-up day 1 (119 [62%] vs 144 [75%] of 193; P = .01). Multivariate analysis showed that before the POS, patients had an 89% higher chance of achieving CIP on follow-up day 1 (odds ratio, 1.89; 95% CI, 1.22-2.94; P = .005).
Conclusions and relevance: There was a significant change in opioid prescription patterns associated with the POS. Furthermore, after the POS, fewer patients achieved CIP. These factors have potential implications for patient satisfaction and hospital length of stay.
Similar articles
-
Opioid prescribing attitudes of palliative care physicians versus other specialists: a questionnaire-based survey.Postgrad Med J. 2022 Feb;98(1156):119-123. doi: 10.1136/postgradmedj-2020-139152. Epub 2021 Jan 7. Postgrad Med J. 2022. PMID: 33414178
-
Opioid Prescribing Patterns Before and After an Inpatient Palliative Care Consultation.Am J Hosp Palliat Care. 2020 Sep;37(9):738-742. doi: 10.1177/1049909119897260. Epub 2019 Dec 26. Am J Hosp Palliat Care. 2020. PMID: 31876160
-
Factors Associated with Improvement in Uncontrolled Cancer Pain without Increasing the Opioid Daily Dose among Patients Seen by an Inpatient Palliative Care Team.J Palliat Med. 2020 Apr;23(4):483-488. doi: 10.1089/jpm.2019.0243. Epub 2019 Nov 5. J Palliat Med. 2020. PMID: 31687882
-
Safe Opioid Use, Storage, and Disposal Strategies in Cancer Pain Management.Oncologist. 2019 Nov;24(11):1410-1415. doi: 10.1634/theoncologist.2019-0242. Epub 2019 May 16. Oncologist. 2019. PMID: 31097618 Free PMC article. Review.
-
Framework for opioid stigma in cancer pain.Pain. 2022 Feb 1;163(2):e182-e189. doi: 10.1097/j.pain.0000000000002343. Pain. 2022. PMID: 34010940 Free PMC article. Review.
Cited by
-
Drug Shortage: Causes, Impact, and Mitigation Strategies.Front Pharmacol. 2021 Jul 9;12:693426. doi: 10.3389/fphar.2021.693426. eCollection 2021. Front Pharmacol. 2021. PMID: 34305603 Free PMC article. Review.
-
Management of a parenteral opioid shortage using ASHP guidelines.Am J Health Syst Pharm. 2021 Feb 19;78(5):426-435. doi: 10.1093/ajhp/zxaa425. Am J Health Syst Pharm. 2021. PMID: 33471055 Free PMC article.
-
Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.Oncologist. 2020 Mar;25(3):189-196. doi: 10.1634/theoncologist.2019-0540. Epub 2019 Dec 24. Oncologist. 2020. PMID: 31872911 Free PMC article. Review.
-
Development and validation of the nomogram to predict the risk of hospital drug shortages: A prediction model.PLoS One. 2023 Apr 14;18(4):e0284528. doi: 10.1371/journal.pone.0284528. eCollection 2023. PLoS One. 2023. PMID: 37058524 Free PMC article.
-
The United States Drug Enforcement Administration and Prescription Opioid Production Quotas: An End Game of Eradication?J Pain Res. 2020 Oct 19;13:2629-2631. doi: 10.2147/JPR.S285835. eCollection 2020. J Pain Res. 2020. PMID: 33116805 Free PMC article. No abstract available.
References
-
- Koyyalagunta D, Bruera E, Solanki DR, et al. . A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician. 2012;15(3)(suppl):ES39-ES58. - PubMed
